Shandong Weigao boosts treasury holdings with share repurchase

Shandong Weigao Group Medical Polymer Company Limited reported a repurchase of 920,000 H shares on December 9, 2025. The shares were bought on the Exchange at prices ranging from HK$5.28 to HK$5.42, with an aggregate price paid of HK$4,929,200. This transaction increased the company's treasury shares from 28,129,200 to 29,049,200.

Following the repurchase, the number of issued shares (excluding treasury shares) decreased by 920,000 to 4,493,283,124, representing a 0.0205% change from the opening balance. The total number of issued shares remains unchanged at 4,522,332,324.

The repurchase was made under a mandate granted on May 27, 2025, which authorized the repurchase of up to 451,560,392 shares. As of December 9, 2025, the total number of shares repurchased under this mandate on the Exchange is 22,400,800, representing 4.9608% of the issued shares (excluding treasury shares) at the mandate date. A moratorium period for new share issues or treasury share transfers is in effect until January 8, 2026.